Federal contract award
75N93022C00061
A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $28.2M |
| Current contract value | $28.2M |
| Potential contract value / ceiling | $28.2M |
| Start date | Sep 22, 2022 |
| Current end date | Apr 25, 2028 |
| Potential end date | Apr 25, 2028 |
| Latest award activity | Jul 10, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 13 of 13 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 10, 2026 | P00012 | $0 | EO14398 A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| Jul 1, 2026 | P00011 | $0 | EO14398 A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| May 6, 2026 | P00010 | $327.2K | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| Mar 23, 2026 | P00009 | $10.0M | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| Dec 30, 2025 | P00008 | $1.8M | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| Apr 28, 2025 | P00007 | $0 | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| Sep 10, 2024 | P00006 | $1.8M | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| Aug 5, 2024 | P00005 | $2.7M | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| Jul 10, 2024 | P00004 | $0 | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| May 10, 2024 | P00003 | $0 | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| Mar 1, 2024 | P00002 | $6.7M | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| Feb 16, 2024 | P00001 | $0 | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
| Sep 22, 2022 | 0 | $4.8M | A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. |
Estimated positioning window
Apr 25, 2027 – Oct 25, 2027
70/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 70/100. Available recorded signals: 65 points.
- Contract end 2028-04-25 (541 days from calculation)
- +25 points
- 155 historical awards in this buyer and category group
- +15 points
- 13 recorded award transactions
- +10 points
- Latest award action: 2026-07-10
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| George Kennedy | Contact | kennedyg@mail.nih.gov 240-669-5170 | Source | Sep 25, 2020 |
| Tiffany Chadwick | Contact | tiffany.chadwick@nih.gov 240-276-7293 | Source | Sep 25, 2020 |
| George Kennedy | Contact | kennedyg@mail.nih.gov 240-669-5170 | Source | Jul 28, 2020 |
| Tiffany Chadwick | Contact | tiffany.chadwick@nih.gov 240-276-7293 | Source | Jul 28, 2020 |
| George Kennedy | Contact | kennedyg@mail.nih.gov 240-669-5170 | Source | Jul 9, 2020 |
| Tiffany Chadwick | Contact | tiffany.chadwick@nih.gov 240-276-7293 | Source | Jul 9, 2020 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.